Keywords: reproducibility, continuous-integration, continuous-deployment, R
The landscape of data science tools and technology is rapidly evolving at a pace that can be challenging to accommodate in a heavily regulated industry like Pharma. Here I’ll present a vision for regulatory reporting that allows us to grow with technology, enabling faster response to changes in patient health during the course of a clinical trial, improved reproducibility of analysis and expedited filing for new drug designations. Specifically, we’ll discuss how containerized analytic environments, regimented version control, leveraging open standards for software development, and continuous integration with analytic code are driving a future of more transparent, faster, more reproducible clinical research and development.